MartinF. Mckneally

655 citations
6 papers · 431 indexed · h-index 5
Topics
Cancer Research and Treatments (2 papers)Lung Cancer Diagnosis and Treatment (2 papers)Cancer Immunotherapy and Biomarkers (2 papers)
Partner nations
United StatesIndiaCanada

In The Last Decade

MartinF. Mckneally

6 papers receiving 350 citations

Peers

MartinF. Mckneally
Comparison fields: 5 of 69
  • Oncology 145
  • Immunology 115
  • Pulmonary and Respiratory Medicine 79
  • Biochemistry 76
  • Epidemiology 70
Replace Charles D. Severson with:
Charles D. Severson United States
Kamala Balakrishnan United States
Kimimasa Ikeda Japan
Lisa Y. Cho South Korea
Elisabeth Lippert Germany
M Vijayaraghavan India
Chandralekha Duttagupta India
Lara Termini Brazil
Steven M. Debol United States
S. Beattie Ireland
MartinF. Mckneally relative to Charles D. Severson United States Charles D. Severson's profile →
Citations per field
00.5×3.8×
Charles D. Severson · 1×
Citations per year

Countries citing papers authored by MartinF. Mckneally

Since Specialization
Citations

This map shows the geographic impact of MartinF. Mckneally's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by MartinF. Mckneally with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites MartinF. Mckneally more than expected).

Fields of papers citing papers by MartinF. Mckneally

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by MartinF. Mckneally. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by MartinF. Mckneally. The network helps show where MartinF. Mckneally may publish in the future.

Co-authorship network of co-authors of MartinF. Mckneally

This figure shows the co-authorship network connecting the top 25 collaborators of MartinF. Mckneally. A scholar is included among the top collaborators of MartinF. Mckneally based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with MartinF. Mckneally. MartinF. Mckneally is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

About MartinF. Mckneally

MartinF. Mckneally is a scholar working on Biotechnology, Virology and Biochemistry, having authored 6 papers that have together received 431 indexed citations. Recurring topics across this work include Cancer Research and Treatments (2 papers), Lung Cancer Diagnosis and Treatment (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). The work is most often cited by research in Biochemistry (76 citations), Immunology (115 citations) and Oncology (145 citations). MartinF. Mckneally has collaborated with scholars based in United States, India and Canada. Frequent co-authors include Carole Maver, RobertA. Good, Dwight T. Janerich, S. T. Mayne, Sherry Chorost, M R Melamed, Muhammad Zaman, Michele Kiely, Christopher Tucci and Peter Greenwald. Their work appears in journals such as The Lancet, Journal of Clinical Oncology and JNCI Journal of the National Cancer Institute.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026